Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer
PaperCitations, authors & open-access status
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 121 citations, 2023 year and hybrid oa status.
121
Citations
2023
Year
hybrid
OA Status